Transworld brokers sale of Nigerian pharma firm by 84-year-old founder

A fully licensed Nigerian pharmaceutical manufacturing company has changed ownership after its 84-year-old founder sold a majority stake to a group of young Nigerian entrepreneurs, in a deal brokered by Transworld Business Advisors Nigeria.

A release by Transworld Business Advisors Nigeria on Thursday, August 13, 2026 signed by Mr. Teslim Belo-Osagie, stated that the sale process was launched on January 31, 2026, and closed in July 2026 — a start-to-finish timeline of under six months for a regulated pharmaceutical-sector transaction.

However, the identities of the company, the seller, the acquiring group, and the transaction value were not disclosed as the entities preferred to remain confidential, with the deal disclosed strictly on a no-name basis.

What Transworld Business Advisors is saying

The transaction centres on a succession decision by the company’s principal shareholder, who at 84 sought to retire and transition ownership responsibly rather than allow a licensed asset to sit idle. In place of a public sale process, the opportunity was sourced off-market through Transworld’s professional network, with a banker relationship originating the introduction.

• “This transaction is a strong example of how thoughtful deal structuring can bring the right asset to the right owners. We were able to honor a founder’s wish to retire on fair terms while giving a talented group of young Nigerian entrepreneurs a genuine platform to enter pharmaceutical manufacturing. Introducing a seller-financing framework was central to making the deal work for everyone involved,” said Teslim Belo-Osagie, Transworld Business Advisors Nigeria.

According to him, the acquired business is a fully NAFDAC-licensed pharmaceutical manufacturer with a portfolio of registered drug names and installed production equipment for orals, liquids, and gels.

Although non-operational at the time of sale, the facility retained its licenses, product registrations, and equipment intact, positioning it as a ready-to-activate platform for the incoming owners.

Transworld also structured a seller-financing arrangement to bridge the valuation gap between the retiring founder and the buyers’ capital position at closing.

The retiring shareholder secured liquidity at closing plus a payout schedule over two years, while the acquiring group was able to take control and begin activating the asset without paying the full purchase price upfront.

More insights:

The buyers represent a growing category of Nigerian entrepreneurs pursuing what is known as Entrepreneurship by Acquisition (ETA) — expanding into a new sector by acquiring an established, licensed platform rather than building one from scratch.

• The acquiring team brings prior operating experience from an adjacent healthcare segment into their new venture in drug manufacturing. What they probably needed is pharmaceutical manufacturing and regulatory infrastructure.
• NAFDAC licensing and drug registrations can take years to assemble, making dormant but fully licensed facilities valuable acquisition targets for operators looking to move quickly into commercial-scale production.
• A NAFDAC approval follows strict adherence to Good Manufacturing Practice (GMP) guidelines set by the World Health Organization (WHO) and NAFDAC GMP for Medicinal Products Regulations 2021.

The seller-financing framework introduced by the firm, the advisor added, was central to making the arrangement work for both sides.

What you should know

The deal adds to a pattern of generational ownership transitions playing out across Nigerian family-owned and founder-led businesses.

• Ageing proprietors are increasingly turning to structured merger and acquisition (M&A) processes — rather than informal succession — to exit on fair terms while keeping licensed, capital-intensive assets in productive use.
• Transworld Business Advisors is a global business brokerage and advisory firm operating in Nigeria, guiding buyers and sellers through business sales, acquisitions, and financing.

The firm said the transaction illustrates the value professional brokers add in regulated-sector deals — from confidential, off-market sourcing to structuring and process discipline that keeps diligence and negotiation on track through closing.